B-Ab15-04 Painesd Risk Score as a Predictor of Outcomes in Electrical Storm

Parker, Joshua; Hedley, Jeffrey; Incognito, Cameron; Gangidi, Shravani; Wazni, Oussama; Rickard, John

doi:10.1016/j.hrthm.2021.06.090

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to PAINESD, elderly diabetic patients with ICM and low LVEF that develop ES and HF have the highest risk of developing cardiogenic shock. Subsequent studies have indicated its ability to also predict mortality VT ablation, yet certain studies have reported conflicting results regarding its accuracy, particularly regarding recurrences [ 32 , 33 , 34 ]. Existing data demonstrate different clinical trajectories in Kaplan–Meier or Cox regression in different PAINESD classes, yet no ROC curve analyses are available.…”

Section: Discussionmentioning

confidence: 99%

MSA-VT Score for Assessment of Long-Term Prognosis after Electrical Storm Ablation

Vatasescu,

Cojocaru,

Gondos

et al. 2024

Biomedicines

View full text Add to dashboard Cite

Introduction: Prognosis after electrical storm (ES) ablation remains severe, especially in patients with recurrent sustained monomorphic ventricular tachycardia (SMVT) or progressive heart failure (HF). However, single-factor-based prediction is suboptimal and may be refined by more complex algorithms. We sought to evaluate if a novel score MSA-VT (M = moderate/severe mitral regurgitation, S = severe HF at admission, A = atrial fibrillation at admission, VT = inducible SMVT after ablation) may improve prediction of death and recurrences compared to single factors and previous scores (PAINESD, RIVA and I-VT). Methods: A total of 101 consecutive ES ablation patients were retrospectively analyzed over a 32.8-month (IQR 10-68) interval. The MSA-VT score was calculated as the sum of the previously mentioned factors’ coefficients based on hazard ratio values in Cox regression analysis. The AUC for death prediction by MSA-VT was 0.84 (p < 0.001), superior to PAINESD (AUC 0.63, p = 0.03), RIVA (AUC 0.69, p = 0.02) and I-VT (0.56, p = 0.3). MSA-VT ≥ 3 was associated with significantly higher mortality during follow-up (52.7%, p < 0.001). Conclusions: Prediction by single factors and previously published scores after ES ablation may be improved by the novel MSA-VT score; however, this requires further external validation in larger samples.

show abstract

Section: Discussionmentioning

confidence: 99%